共 50 条
- [21] A phase II study of etoposide, methylprednisolone, high-dose cytarabine, and oxaliplatin (ESHAOx) for patients with refractory or relapsed Hodgkin’s lymphoma Annals of Hematology, 2020, 99 : 255 - 264
- [25] High-dose chemotherapy and autologous stem-cell transplantation in Korean patients with relapsed or refractory Hodgkin lymphoma International Journal of Hematology, 2013, 97 : 256 - 262
- [26] COMPLETE RESPONSE TO IGEV (IFOSFAMIDE, GEMCITABINE AND VINORELBINE) AND OUTCOME IN RELAPSED/REFRACTORY HODGKIN'S LYMPHOMA PATIENTS HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 37 - 37
- [30] Ifosfamide, gemcitabine, and vinorelbine: a now induction regimen for refractory and relapsed Hodgkin's lymphoma HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (01): : 35 - 41